On the contrary, some authors claim that high visfatin/Nampt levels, instead of depicting changes in the atherosclerotic process are more likely reflecting changes in the systemic inflammation in patients with renal and cardiovascular disease. Here, NAMPT is linked to cardiovascular disorder.